Globus Medical (GMED) Depreciation & Amortization (CF) (2011 - 2026)

Globus Medical (GMED) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $69.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 1.6% year-over-year to $69.5 million; the trailing twelve-month figure through Jun 2026 stood at $279.9 million (up 3.36% YoY), and the FY2025 full-year result was $276.8 million, up 9.26% from the prior year.
• Depreciation & Amortization (CF) fell to $69.5 million in Q2 2026 per GMED's latest filing, from $69.9 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $72.0 million in Q4 2023 and bottomed at $16.8 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $49.1 million across 5 years, with a median of $64.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) dropped 11.52% in 2022, then surged 325.52% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $16.9 million in 2022, then jumped by 325.52% to $72.0 million in 2023, then slipped by 6.06% to $67.6 million in 2024, then advanced by 2.1% to $69.0 million in 2025, then rose by 0.71% to $69.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $69.5 million, $69.9 million, and $69.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.